Inspiratory Muscle Training for Postmenopausal Women
(MRS Trial)
Trial Summary
Yes, if you are currently using prescription medications that affect heart rate or blood vessel dilation, you will need to stop taking them to participate in this trial.
Inspiratory muscle training (IMT) has been shown to improve functional outcomes and physical performance in older women, suggesting it could be beneficial for postmenopausal women as well.
12345The PrO2 Fit (IMT Trainer) is unique because it focuses on strengthening the inspiratory muscles (muscles used for breathing in), which is different from traditional resistance training that targets overall muscle strength and body composition. This device offers a novel approach by specifically enhancing respiratory muscle function, which can improve breathing efficiency and potentially benefit overall physical performance in postmenopausal women.
12467Eligibility Criteria
This trial is for postmenopausal women who are interested in how strengthening breathing muscles might improve heart health and mood. Details on specific inclusion or exclusion criteria were not provided, so it's best to contact the study team for more information.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo inspiratory muscle training (IMT) or sham IMT for 8 weeks, 4 times a week
Follow-up
Participants are monitored for safety and effectiveness after treatment
Participant Groups
PrO2 Fit (IMT Trainer) is already approved in United States for the following indications:
- Rehabilitation for respiratory conditions
- Improvement of respiratory muscle strength and endurance